Related Experiment Video
Updated: Aug 18, 2026
Optimization of High Grade Glioma Cell Culture from Surgical Specimens for Use in Clinically Relevant Animal Models and 3D Immunochemistry
Published on: January 7, 2014
Establishment and characterization of a new human glioblastoma cell line, NYGM
Yoshitsugu Nuki1, Shunro Uchinokura, Shiro Miyata
1Department of Neurosurgery, Faculty of Medicine, University of Miyazaki.
Abstract:
A cell line designated NYGM was established from a human cerebral glioblastoma multiforme (GBM) obtained from a 75-year-old Japanese woman. The cell line has grown slowly without interruption and has been propagated continuously by serial passages (more than 80 passage) during the past 3 years. The cultured cells were fusiform or polyhedral in shape. The population doubling time was 24 hours. The chromosomal number varied between 77 and 88, with modal chromosomal number of 84. NYGM cells concomitantly expressed MET receptor tyrosine kinase (a product of c-met protooncogene) and its ligand HGF/SF (hepatocyte growth factor/scatter factor), as well as HGF activator and HGF activator inhibitors. The cells might be useful for the study of pericellular regulation of HGF/SF-MET signaling and HGF activation of GBM cells.
Insights
A new human glioblastoma cell line, NYGM, was developed from patient tissue. This cell line expresses key signaling molecules, making it valuable for glioblastoma research.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Glioblastoma multiforme (GBM) is an aggressive brain tumor with limited treatment options.
- Establishing reliable cell lines is crucial for understanding GBM biology and developing new therapies.
Observation:
- A novel human glioblastoma cell line, NYGM, was derived from a 75-year-old Japanese female patient.
- The NYGM cell line exhibits stable growth over 3 years with over 80 passages.
- Cells display fusiform to polyhedral morphology with a population doubling time of 24 hours and a modal chromosome number of 84.
Findings:
- NYGM cells express MET receptor tyrosine kinase (c-met protooncogene product) and its ligand, hepatocyte growth factor/scatter factor (HGF/SF).
- The cells also express HGF activator and HGF activator inhibitors.
- This co-expression suggests intrinsic HGF/SF-MET signaling pathway activity within the NYGM cell line.
Implications:
- The NYGM cell line provides a valuable model for studying the pericellular regulation of HGF/SF-MET signaling.
- It can be used to investigate HGF activation mechanisms in glioblastoma cells.
- This resource may aid in the development of targeted therapies for glioblastoma.
